摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Ethyl-α-cyano-4-methyl-3-nitro-2-pyridinacetat | 56057-20-6

中文名称
——
中文别名
——
英文名称
Ethyl-α-cyano-4-methyl-3-nitro-2-pyridinacetat
英文别名
cyano-(4-methyl-3-nitro-pyridin-2-yl)-acetic acid ethyl ester;Ethyl 2-cyano-2-(4-methyl-3-nitropyridin-2-yl)acetate
Ethyl-α-cyano-4-methyl-3-nitro-2-pyridinacetat化学式
CAS
56057-20-6
化学式
C11H11N3O4
mdl
——
分子量
249.226
InChiKey
VHSRZSPXKKNZLO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    109
  • 氢给体数:
    0
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    DAISLEY R. W.; HANBALI J. R., SYNTH. COMMUN., 1975, 5, NO 1, 53-57
    摘要:
    DOI:
  • 作为产物:
    描述:
    2-氯-4-甲基-3-硝基吡啶氰乙酸乙酯potassium tert-butylate 作用下, 以 异丙醇叔丁醇 为溶剂, 反应 6.08h, 以74%的产率得到Ethyl-α-cyano-4-methyl-3-nitro-2-pyridinacetat
    参考文献:
    名称:
    Design, synthesis, antitubercular and antibacterial activities of pyrrolo[3,2-b]pyridine-3-carboxamide linked 2-methoxypyridine derivatives and in silico docking studies
    摘要:
    A novel series pyrrolo[3,2-b]pyridine-3-carboxamide linked 2-methoxypyridine derivatives have been designed, synthesized and confirmed by FT-IR, H-1 NMR, C-13 NMR, F-19 NMR, MS, and elemental analysis. The synthesized compounds were screened for their antitubercular activity using microplate alamar blue assay method and antibacterial activity. Among the tested compounds, 4- fluorophenyl (8m), 4- chlorophenyl (8n) and 4-methoxyphenyl (8i) showed potent anti-TB activity (3.12 mu g/mL) in comparison with reference drug, Pyrazinamide ((3.12 mu g/mL). In addition, all compounds were docked into DprE1 (PDB code: 4KW5) to explore their binding interactions at the active site. The compounds exhibited essential key interactions as that of reported DprE1 inhibitors and hence, the synthesized compounds may be considered as molecular scaffolds for antitubercular activity. Compounds, 4-chlorophenyl (8n) and 4-flurophenyl (8m) showed significant antibacterial activity against Escherichia coli and Staphylococcus aureus strains. In silico prediction of toxicities, druglikeness and drug score profiles of the tested compounds are promising.
    DOI:
    10.1080/00397911.2019.1618874
点击查看最新优质反应信息

文献信息

  • Design, synthesis, antitubercular and antibacterial activities of pyrrolo[3,2-b]pyridine-3-carboxamide linked 2-methoxypyridine derivatives and <i>in silico</i> docking studies
    作者:Srinu Bodige、Parameshwar Ravula、Kali Charan Gulipalli、Srinivas Endoori、Purna Koteswara Rao Cherukumalli、Narendra Sharath Chandra JN、Nareshvarma Seelam
    DOI:10.1080/00397911.2019.1618874
    日期:2019.9.2
    A novel series pyrrolo[3,2-b]pyridine-3-carboxamide linked 2-methoxypyridine derivatives have been designed, synthesized and confirmed by FT-IR, H-1 NMR, C-13 NMR, F-19 NMR, MS, and elemental analysis. The synthesized compounds were screened for their antitubercular activity using microplate alamar blue assay method and antibacterial activity. Among the tested compounds, 4- fluorophenyl (8m), 4- chlorophenyl (8n) and 4-methoxyphenyl (8i) showed potent anti-TB activity (3.12 mu g/mL) in comparison with reference drug, Pyrazinamide ((3.12 mu g/mL). In addition, all compounds were docked into DprE1 (PDB code: 4KW5) to explore their binding interactions at the active site. The compounds exhibited essential key interactions as that of reported DprE1 inhibitors and hence, the synthesized compounds may be considered as molecular scaffolds for antitubercular activity. Compounds, 4-chlorophenyl (8n) and 4-flurophenyl (8m) showed significant antibacterial activity against Escherichia coli and Staphylococcus aureus strains. In silico prediction of toxicities, druglikeness and drug score profiles of the tested compounds are promising.
  • DAISLEY R. W.; HANBALI J. R., SYNTH. COMMUN., 1975, 5, NO 1, 53-57
    作者:DAISLEY R. W.、 HANBALI J. R.
    DOI:——
    日期:——
查看更多